Chevallard Daniel R.
- SEC CIK
- 0001706176
In the past year, 2 open-market purchase filings worth $114.3K and no sales.
Current role at each company
- LENZ LENZ Therapeutics, Inc.Chief Financial Officeras of Mar 30, 2026
- VIRX Viracta Therapeutics, Inc.CFO and COOas of Mar 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $114.3K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$114.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chevallard Daniel R. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LENZ LENZ Therapeutics, Inc.
Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 (view filing) | Mar 27 | 3 days | Chevallard Daniel R.Chief Financial Officer | PPurchase | +7.50K | $8.57 | +$64.3K | +139.2%12.9K after | |
| Nov 7, 2025 (view filing) | Nov 7 | Same day | Chevallard Daniel R.Chief Financial Officer | PPurchase | +2.20K | $22.76 | +$50.0K | +68.9%5.39K after | 2 lots |
| May 15, 2024 (view filing) | May 14 | 1 day | Chevallard Daniel R.Chief Financial Officer | PPurchase | +3.19K | $15.68 | +$50.0K | New position3.19K after |
VIRX Viracta Therapeutics, Inc.
CFO and COO10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 (view filing) | Feb 27 | Same day | Chevallard Daniel R.CFO and COO | SSale | −3.40K | $0.73 | −$2.49K | −3.2%102.3K after | |
| Nov 28, 2023 (view filing) | Nov 28 | Same day | Chevallard Daniel R.CFO and COO | SSale | −3.72K | $0.50 | −$1.86K | −3.6%98.8K after | |
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −3.51K | $1.45 | −$5.09K | −3.5%95.7K after | |
| May 26, 2023 (view filing) | May 25 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −3.63K | $1.42 | −$5.16K | −3.8%92.3K after | |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −3.60K | $1.68 | −$6.05K | −3.9%89.0K after | |
| Nov 29, 2022 (view filing) | Nov 28 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −3.53K | $2.72 | −$9.61K | −4.0%85.7K after | |
| Aug 29, 2022 (view filing) | Aug 26 | 3 days | Chevallard Daniel R.CFO and COO | SSale | −3.65K | $4.02 | −$14.7K | −4.2%82.4K after | |
| May 27, 2022 (view filing) | May 26 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −3.60K | $1.90 | −$6.83K | −4.3%79.1K after | |
| Mar 1, 2022 (view filing) | Feb 28 | 1 day | Chevallard Daniel R.CFO and COO | SSale | −4.00K | $2.78 | −$11.1K | −5.0%75.8K after | |
| Nov 29, 2021 (view filing)7:48 PM ET | Nov 26-29 | 3 days | Chevallard Daniel R.CFO and COO | SSale | −7.58K | $4.81 | −$36.5K | −9.4%73.0K after | 2 lots |